The DOI matches its Crossref record; 258 of the 258 references it cites were found in a registry or an index.
Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
Open accessAbstract
Chronic (continuous, non-interrupted) hypoxia and cycling (intermittent, transient) hypoxia are two types of hypoxia occurring in malignant tumors. They are both associated with the activation of hypoxia-inducible factor-1 (HIF-1) and nuclear factor κB (NF-κB), which induce changes in gene expression. This paper discusses in detail the mechanisms of activation of these two transcription factors in chronic and cycling hypoxia and the crosstalk between both signaling pathways. In particular, it focuses on the importance of reactive oxygen species (ROS), reactive nitrogen species (RNS) together with nitric oxide synthase, acetylation of HIF-1, and the action of MAPK cascades. The paper also discusses the importance of hypoxia in the formation of chronic low-grade inflammation in cancerous tumors. Finally, we discuss the effects of cycling hypoxia on the tumor microenvironment, in particular on the expression of VEGF-A, CCL2/MCP-1, CXCL1/GRO-α, CXCL8/IL-8, and COX-2 together with PGE2. These factors induce angiogenesis and recruit various cells into the tumor niche, including neutrophils and monocytes which, in the tumor, are transformed into tumor-associated neutrophils (TAN) and tumor-associated macrophages (TAM) that participate in tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.025 · Cited by 1,613
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., & Harris, A. L. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64554-3 · Cited by 1,312
Garcia, J., Hurwitz, H. I., Sandler, A. B., Miles, D., Coleman, R. L., Deurloo, R., & Chinot, O. L. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102017 · Cited by 1,159
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici, C. S., Boşca, A. B., Șușman, S., Mărginean, M. V., Mihu, C., Istrate, M., Moldovan, I. M., Roman, A. L., & Mihu, C. M. (2018) · PubMed · Cited by 1,146
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794
Richard, D. E., Berra, E., Gothié, E., Roux, D., & Pouysségur, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32631 · Cited by 790
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782
Cellular abnormalities of blood vessels as targets in cancer
Baluk, P., Hashizume, H., & McDonald, D. M. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.005 · Cited by 781
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758
Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Patterson, K. I., Brummer, T., O'brien, P. M., & Daly, R. J. (2009) · Biochemical Journal · doi:10.1042/bj20082234 · Cited by 744
Regulation of hypoxia-inducible factor-1α by NF-κB
van Uden, P., Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20080476 · Cited by 729
Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation
Jeong, J.-W., Bae, M.-K., Ahn, M.-Y., Kim, S.-H., Sohn, T.-K., Bae, M.-H., Yoo, M.-A., Song, E. J., Lee, K.-J., & Kim, K.-W. (2002) · Cell · doi:10.1016/s0092-8674(02)01085-1 · Cited by 716
Reactive Oxygen Species Activate the HIF-1α Promoter Via a Functional NFκB Site
Bonello, S., Zähringer, C., BelAiba, R. S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T., & Görlach, A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258979.92828.bc · Cited by 628
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors
Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., & McDonald, D. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63540-7 · Cited by 528
Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612920114 · Cited by 494
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Regulation of HIF-1α Stability through S-Nitrosylation
Li, F., Sonveaux, P., Rabbani, Z. N., Liu, S., Yan, B., Huang, Q., Vujaskovic, Z., Dewhirst, M. W., & Li, C.-Y. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.024 · Cited by 437
BelAiba, R. S., Bonello, S., Zähringer, C., Schmidt, S., Hess, J., Kietzmann, T., & Görlach, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0391 · Cited by 423
Dhup, S., Kumar Dadhich, R., Ettore Porporato, P., & Sonveaux, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504902 · Cited by 420
Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0791 · Cited by 414
Cancer CXC chemokine networks and tumour angiogenesis
Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B., Keane, M. P., & Belperio, J. A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.006 · Cited by 410
Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response
Dames, S. A., Martinez-Yamout, M., De Guzman, R. N., Dyson, H. J., & Wright, P. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082121399 · Cited by 402
Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
Itatani, Y., Kawada, K., Yamamoto, T., & Sakai, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041232 · Cited by 346
Loberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Fang, H.-Y., Hughes, R., Murdoch, C., Coffelt, S. B., Biswas, S. K., Harris, A. L., Johnson, R. S., Imityaz, H. Z., Simon, M. C., Fredlund, E., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195941 · Cited by 319
Yuan, G., Nanduri, J., Khan, S., Semenza, G. L., & Prabhakar, N. R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21537 · Cited by 310
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Deryugina, E. I., Zajac, E., Juncker-Jensen, A., Kupriyanova, T. A., Welter, L., & Quigley, J. P. (2014) · Neoplasia · doi:10.1016/j.neo.2014.08.013 · Cited by 304
Qian, D. Z., Kachhap, S. K., Collis, S. J., Verheul, H. M. W., Carducci, M. A., Atadja, P., & Pili, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4598 · Cited by 299
Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298
The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-inducible Factor-1
Diebold, I., Petry, A., Hess, J., & Görlach, A. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-12-1003 · Cited by 296
Chen, X., Li, X., Zhang, W., He, J., Xu, B., Lei, B., Wang, Z., Cates, C., Rousselle, T., & Li, J. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.004 · Cited by 294
(2001) · PubMed · Cited by 292
Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289
Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes
Kulisz, A., Chen, N., Chandel, N. S., Shao, Z., & Schumacker, P. T. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00326.2001 · Cited by 286
Hypoxia Up-regulates Prolyl Hydroxylase Activity
D'Angelo, G., Duplan, E., Boyer, N., Vigne, P., & Frelin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302244200 · Cited by 285
Greene, S., Robbins, Y., Mydlarz, W. K., Huynh, A. P., Schmitt, N. C., Friedman, J., Horn, L. A., Palena, C., Schlom, J., Maeda, D. Y., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2625 · Cited by 280
Bilusic, M., Heery, C. R., Collins, J. M., Donahue, R. N., Palena, C., Madan, R. A., Karzai, F., Marté, J. L., Strauss, J., Gatti-Mays, M. E., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0706-x · Cited by 274
Korbecki, J., Kojder, K., Kapczuk, P., Kupnicka, P., Gawrońska-Szklarz, B., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020843 · Cited by 273
Self-citationSandhu, S. K., Papadopoulos, K., Fong, P. C., Patnaik, A., Messiou, C., Olmos, D., Wang, G., Tromp, B. J., Puchalski, T. A., Balkwill, F., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2099-8 · Cited by 272
Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., & Simos, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605058200 · Cited by 266
PHDs overactivation during chronic hypoxia “desensitizes” HIFα and protects cells from necrosis
Ginouvès, A., Ilc, K., Macías, N., Pouysségur, J., & Berra, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705680105 · Cited by 256
Muller, A. J., Sharma, M. D., Chandler, P. R., DuHadaway, J. B., Everhart, M. E., Johnson, B. A., Kahler, D. J., Pihkala, J., Soler, A. P., Munn, D. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806173105 · Cited by 240
Do, H. T. T., Lee, C. H., & Cho, J. (2020) · Cancers · doi:10.3390/cancers12020287 · Cited by 234
Luo, W., Zhong, J., Chang, R., Hu, H., Pandey, A., & Semenza, G. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068577 · Cited by 232
Zhang, P., Yao, Q., Lu, L., Li, Y., Chen, P.-J., & Duan, C. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.011 · Cited by 231
Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia
Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H., & Fujii-Kuriyama, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7368 · Cited by 224
Mechanism of Hypoxia-Induced NF-κB
Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., & Rocha, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00409-10 · Cited by 223
VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
Hawinkels, L. J. A. C., Zuidwijk, K., Verspaget, H. W., de Jonge-Muller, E. S. M., Duijn, W. V., Ferreira, V., Fontijn, R. D., David, G., Hommes, D. W., Lamers, C. B. H. W., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.031 · Cited by 211
Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K., & Blagosklonny, M. V. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1734-1741.2002 · Cited by 207
Analysis of the intricate relationship between chronic inflammation and cancer
Chai, E. Z. P., Siveen, K. S., Shanmugam, M. K., Arfuso, F., & Sethi, G. (2015) · Biochemical Journal · doi:10.1042/bj20141337 · Cited by 202
Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., & Mukaida, N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1451 · Cited by 200
HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
Geng, H., Harvey, C. T., Pittsenbarger, J., Liu, Q., Beer, T. M., Xue, C., & Qian, D. Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257055 · Cited by 197
Kato, H., Tamamizu-Kato, S., & Shibasaki, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406320200 · Cited by 196
Contribution of regulatory T cells to cancer: A review
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27553 · Cited by 195
Chua, Y. L., Dufour, E., Dassa, E. P., Rustin, P., Jacobs, H. T., Taylor, C. T., & Hagen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158485 · Cited by 189
Wang, R., Zhang, J., Chen, S., Lu, M., Luo, X., Yao, S., Liu, S., Qin, Y., & Chen, H. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.04.009 · Cited by 189
Scholz, C. C., Cavadas, M. A. S., Tambuwala, M. M., Hams, E., Rodríguez, J., Kriegsheim, A. V., Cotter, P., Bruning, U., Fallon, P. G., Cheong, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309718110 · Cited by 186
Yang, S., Wu, C., XIONG, Z.-F., & Fang, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3689 · Cited by 185
HIF1α Protein Stability Is Increased by Acetylation at Lysine 709
Geng, H., Liu, Q., Xue, C., David, L. L., Beer, T. M., THOMAS, G. V., Dai, M., & Qian, D. Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400697 · Cited by 184
Schultheis, A. M., Lurje, G., Rhodes, K. E., Zhang, W., Yang, D., Garcia, A. A., Morgan, R., Gandara, D., Scudder, S., Oza, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0351 · Cited by 182
CXCR2‐mediated tumor‐associated neutrophil recruitment is regulated by IFN‐β
Jablonska, J., Wu, C. ‐., Andzinski, L., Leschner, S., & Weiss, S. (2014) · International Journal of Cancer · doi:10.1002/ijc.28551 · Cited by 179
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
Tu, M. M., Abdel-Hafiz, H. A., Jones, R. T., Jean, A., Hoff, K. J., Duex, J. E., Chauca-Diaz, A., Costello, J. C., Dancik, G. M., Tamburini, B. A. J., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01441-y · Cited by 178
The Pervasive Presence of Fluctuating Oxygenation in Tumors
Cárdenas-Navia, L. I., Mace, D., Richardson, R. A., Wilson, D. F., Shan, S., & Dewhirst, M. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6387 · Cited by 176
Salcedo, R., Zhang, X., Young, H. A., Michael, N., Wasserman, K., Ma, W.-H., Martins-Green, M., Murphy, W. J., & Oppenheim, J. J. (2003) · Blood · doi:10.1182/blood-2002-11-3400 · Cited by 175
Rofstad, E. K., Gaustad, J., Egeland, T. A. M., Mathiesen, B., & Galappathi, K. (2010) · International Journal of Cancer · doi:10.1002/ijc.25176 · Cited by 173
Scortegagna, M., Cataisson, C., Martin, R. J., Hicklin, D. J., Schreiber, R. D., Yuspa, S. H., & Arbeit, J. M. (2008) · Blood · doi:10.1182/blood-2007-10-115758 · Cited by 172
Regulation of the HIF-1α stability by histone deacetylases
Kim, S. H., Jeong, J.-W., Park, J. Y., Lee, J., Seo, J., Jung, B., Bae, M., & Kim, K. (2007) · Oncology Reports · doi:10.3892/or.17.3.647 · Cited by 170
Dominguez, C., McCampbell, K. K., David, J. M., & Palena, C. (2017) · JCI Insight · doi:10.1172/jci.insight.94296 · Cited by 170
Burke, B., Tang, N., Corke, K. P., Tazzyman, D., Ameri, K., Wells, M., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1029 · Cited by 169
The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity
Masson, N., Singleton, R. S., Sekirnik, R., Trudgian, D. C., Ambrose, L. J. A., Miranda, M. X., Tian, Y., Kessler, B. M., Schofield, C. J., & Ratcliffe, P. J. (2012) · EMBO Reports · doi:10.1038/embor.2012.9 · Cited by 166
Xue, J., Li, X., Jiao, S., Wei, Y., Wu, G., & Fang, J. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.049 · Cited by 166
Evolutionary Conserved Regulation of HIF-1β by NF-κB
van Uden, P., Kenneth, N. S., Webster, R., Müller, H. A., Mudie, S., & Rocha, S. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001285 · Cited by 163
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 163
Park, A., Lee, Y., Kim, M. S., Kang, Y. J., Park, Y.-J., Jung, H., Kim, T.-D., Lee, H. G., Choi, I., & Yoon, S. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01859 · Cited by 163
Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
Muthuswamy, R., Urban, J., Lee, J.-J., Reinhart, T. A., Bartlett, D., & Kalinski, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6818 · Cited by 162
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
Hubbi, M. E., Hu, H., Gupta, K., Gilkes, D. M., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476903 · Cited by 161
Lanzen, J. L., Braun, R. D., Klitzman, B. M., Brizel, D. M., Secomb, T. W., & Dewhirst, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-03-2958 · Cited by 151
Targeting the NF-κB Pathway in Cancer Therapy
Erstad, D. J., & Cusack, J. C. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.06.011 · Cited by 151
Yuan, X.-L., Chen, L., Li, M.-X., Dong, P., Xue, J., Wang, J., Zhang, T.-T., Wang, X.-A., Zhang, F., Ge, H.-L., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.10.005 · Cited by 149
Malec, V., Gottschald, O. R., Li, S., Rose, F., Seeger, W., & Hänze, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.008 · Cited by 149
Mian, B. M., Dinney, C. P., Bermejo, C. E., Sweeney, P., Tellez, C. S., Yang, X., Gudas, J. M., McConkey, D. J., & Bar‐Eli, M. (2003) · PubMed · Cited by 148
Yuan, G., Adhikary, G., McCormick, A. A., Holcroft, J. J., Kumar, G. K., & Prabhakar, N. R. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.058503 · Cited by 147
HIF-1α restricts NF-κB dependent gene expression to control innate immunity signals
Bandarra, D., Biddlestone, J., Mudie, S., Müller, H. ‐. J., & Rocha, S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.017285 · Cited by 146
Lu, X., Murphy, T. C., Nanes, M. S., & Hart, C. M. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00090.2010 · Cited by 143
Loetscher, P., Seitz, M., Clark‐Lewis, I., Baggiolini, M., & Moser, B. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80454-0 · Cited by 139
Teng, K., Han, J., Zhang, X., Hsu, S., He, S., Wani, N. A., Barajas, J. M., Snyder, L. A., Frankel, W. L., Caligiuri, M. A., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0124 · Cited by 138
Tumor iNOS predicts poor survival for stage III melanoma patients
Ekmekçioglu, S., Ellerhorst, J. A., Prieto, V. G., Johnson, M. M., Broemeling, L. D., & Grimm, E. A. (2006) · International Journal of Cancer · doi:10.1002/ijc.21767 · Cited by 135
Grossman, J. G., Nywening, T. M., Belt, B. A., Panni, R. Z., Krasnick, B. A., DeNardo, D. G., Hawkins, W. G., Goedegebuure, S. P., Linehan, D. C., & Fields, R. C. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1470729 · Cited by 135
Goldstein, L. J., Perez, R. P., Yardley, D. A., Han, L. K., Reuben, J. M., Gao, H., McCanna, S., Butler, B., Ruffini, P. A., Liu, Y., et al. (2020) · Breast Cancer Research · doi:10.1186/s13058-019-1243-8 · Cited by 135
Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells
Yao, C., Lin, Y., Chua, M., Ye, C., Bi, J., Li, W., Zhu, Y., & Wang, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22930 · Cited by 132
Xin, X., Majumder, M., Girish, G. V., Mohindra, V., Maruyama, T., & Lala, P. K. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.90 · Cited by 132
NO restores HIF-1α hydroxylation during hypoxia: Role of reactive oxygen species
Callapina, M., Zhou, J., Schmid, T., Köhl, R., & Brüne, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.009 · Cited by 131
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylation
Seo, K.-S., Park, J.-H., Heo, J. Y., Jing, K., Han, J., Min, K.-N., Kim, C., Koh, G. Y., Lim, K., Kang, G.-Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.76 · Cited by 131
Kuroda, T., Kitadai, Y., Tanaka, S., Yang, X., Mukaida, N., Yoshihara, M., & Chayama, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0798 · Cited by 129
Tanaka, T., Wiesener, M. S., Bernhardt, W. M., Eckardt, K., & Warnecke, C. (2009) · Biochemical Journal · doi:10.1042/bj20090120 · Cited by 129
Hsieh, C. (2010) · Oncology Reports · doi:10.3892/or_00001027 · Cited by 129
Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice
Yasui, H., Matsumoto, S., Devasahayam, N., Munasinghe, J., Choudhuri, R., Saito, K., Subramanian, S., Mitchell, J. B., & Krishna, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1350 · Cited by 127
Hsieh, C., Shyu, W., Chiang, C.-Y., Kuo, J.-W., Shen, W., & Liu, R.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023945 · Cited by 122
Comerford, K. M., Cummins, E. P., & Taylor, C. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1919 · Cited by 119
Xu, L., Pathak, P. S., & Fukumura, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0953-03 · Cited by 118
Ke, X., Chen, C., Song, Y., Cai, Q., Li, J., Tang, Y., Han, X., Qu, W., Chen, A., Wang, H., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10956 · Cited by 118
A critical role for p38 map kinase in NF-κB signaling during intermittent hypoxia/reoxygenation
Ryan, S., McNicholas, W. T., & Taylor, C. T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.015 · Cited by 115
Lin, S., Chien, C., Lee, J., Yeh, Y.-C., Hsu, K., Lai, Y.-Y., Lin, S.-C., & Tsai, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44362 · Cited by 113
Bullen, J. W., Tchernyshyov, I., Holewinski, R. J., Devine, L. R., Wu, F., Venkatraman, V., KASS, D., Cole, R. N., Eyk, J. E. V., & Semenza, G. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0583 · Cited by 112
Fitzgerald, J. P., Nayak, B., Shanmugasundaram, K., Friedrichs, W. E., Sudarshan, S., Eid, A. A., DeNapoli, T. S., Parekh, D. J., Gorin, Y. C., & Block, K. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030712 · Cited by 109
Liu, Y., Chen, J., Xie, L., Wang, J., Li, T., He, Y. L., Gao, Y., Qin, X. Y., & Li, S. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-55 · Cited by 108
Korbecki, J., Kojder, K., Barczak, K., Simińska, D., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165647 · Cited by 106
Self-citationThe response of c-Jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent
Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G.-C., Mendonca, H. L., Ryan, H. E., Wang, Z., & Johnson, R. S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2515-2523.2002 · Cited by 105
Determination and comparison of specific activity of the HIF‐prolyl hydroxylases
Tuckerman, J. R., Zhao, Y., Hewitson, K. S., Tian, Y., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.005 · Cited by 104
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma, S. H., Lipponen, P., & Kosma, V. M. (2001) · PubMed · Cited by 103
Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion
Li, F., Kitajima, S., Kohno, S., Yoshida, A., Tange, S., Sasaki, S., Okada, N., Nishimoto, Y., Muranaka, H., Nagatani, N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3604 · Cited by 100
Li, L., Ren, F., Qi, C., Xu, L., Fang, Y., Liang, M., Feng, J., Chen, B.-Y., Ning, W., & Cao, J. (2018) · Respiratory Research · doi:10.1186/s12931-018-0727-x · Cited by 99
Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils
Yuan, M., Zhu, H., Xu, J., Zheng, Y., Cao, X., & Liu, Q. (2016) · Journal of Immunology Research · doi:10.1155/2016/6530410 · Cited by 98
Nam, S.-Y., Ko, Y. S., Jung, J. H., Yoon, J., Kim, Y. H., Choi, Y. J., Park, J.-W., Chang, M. S., Kim, W. H., & Lee, B. L. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606020 · Cited by 97
Mills, C. N., Joshi, S. S., & Niles, R. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-104 · Cited by 94
Minet, E., Michel, G., Mottet, D., Piret, J., Barbieux, A., Raes, M. J., & Michiels, C. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5180 · Cited by 92
HIF-1α Activation by Intermittent Hypoxia Requires NADPH Oxidase Stimulation by Xanthine Oxidase
Nanduri, J., Vaddi, D. R., Khan, S. A., Wang, N., Makarenko, V. V., Semenza, G. L., & Prabhakar, N. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119762 · Cited by 90
Regulation of the Ring Finger E3 Ligase Siah2 by p38 MAPK
Khurana, A., Nakayama, K., Williams, S., Davis, R. J., Mustelin, T., & Ronai, Z. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606568200 · Cited by 89
NPI-0052 Enhances Tumoricidal Response to Conventional Cancer Therapy in a Colon Cancer Model
Cusack, J. C., Liu, R., Xia, L., Chao, T., Pien, C. S., Niu, W., Palombella, V. J., Neuteboom, S., & Palladino, M. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1151 · Cited by 89
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Fujita, N., Markova, D., Anderson, D. G., Chiba, K., Toyama, Y., Shapiro, I. M., & Risbud, M. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334466 · Cited by 87
Corn, P. G., McDonald, E. R., Herman, J. G., & El‐Deiry, W. S. (2003) · Nature Genetics · doi:10.1038/ng1254 · Cited by 84
Xanthine Oxidase Mediates Hypoxia-Inducible Factor-2α Degradation by Intermittent Hypoxia
Nanduri, J., Vaddi, D. R., Khan, S. A., Wang, N., Makerenko, V., & Prabhakar, N. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075838 · Cited by 84
Li, Y., Li, Y., Dong, L., Yang, Z., Zhang, J., Zhang, S., Niu, M., Xia, J., Gong, Y., Zhu, N., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0272-2 · Cited by 84
Han, S., Xu, W., Wang, Z., Qi, X., Wang, Y., Ni, Y., Shen, H., Hu, Q., & Han, W. (2016) · Oncotarget · doi:10.18632/oncotarget.9329 · Cited by 83
Ravenna, L., Principessa, L., Verdina, A., Salvatori, L., Russo, M. A., & Petrangeli, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096250 · Cited by 80
Zampetaki, A., Mitsialis, S. A., Pfeilschifter, J. M., & Kourembanas, S. (2004) · The FASEB Journal · doi:10.1096/fj.03-0991fje · Cited by 79
Seta, K. A., Kim, R., Kim, H., Millhorn, D. E., & Beitner‐Johnson, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103346200 · Cited by 79
de Pedro, M., Baeza, S., Escudero, M.-T., Dierssen‐Sotos, T., Gómez‐Acebo, I., Pollán, M., & Llorca, J. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3267-9 · Cited by 78
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 78
Kwon, S., Song, J. J., & Lee, Y. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0981 · Cited by 78
Fujita, N., Gogate, S. S., Chiba, K., Toyama, Y., Shapiro, I. M., & Risbud, M. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375964 · Cited by 76
Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1α stabilization
Köhl, R., Zhou, J., & Brüne, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.012 · Cited by 74
Overexpression of thioredoxin reductase 1 regulates NF‐κB activation
Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M., Imura, N., & Hara, S. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10377 · Cited by 73
Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., & Wen, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3371 · Cited by 73
Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway
Delprat, V., Tellier, C., Demazy, C., Raes, M. J., Féron, O., & Michiels, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57677-5 · Cited by 73
Tafani, M., Russo, A., Vito, M. D., Sale, P., Pellegrini, L., Schito, L., Gentileschi, S., Bracaglia, R., Marandino, F., Garaci, E., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01493.x · Cited by 72
Chen, W.-L., Wang, C.-C., Lin, Y., Wu, C., & Hsieh, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0758-8 · Cited by 72
Seo, H., Kim, E., Na, H., & Lee, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.044 · Cited by 71
Temporal changes in pO2 of R3230Ac tumors in fischer-344 rats
Dewhirst, M. W., Braun, R. D., & Lanzen, J. L. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00304-6 · Cited by 71
Sutton, K., Hayat, S., Chau, N.-M., Cook, S. J., Pouysségur, J., Ahmed, A., Perusinghe, N. P., LeFloch, R., Yang, J., & Ashcroft, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210168 · Cited by 69
Baudelet, C., Cron, G. O., Ansiaux, R., Crokart, N., DeWever, J., Féron, O., & Gallez, B. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1002 · Cited by 69
Feng, H., Liu, K., Shen, X., Liang, J., Wang, C., Qiu, W., Cheng, X., & Zhao, R. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03111-7 · Cited by 68
Baratelli, F. E., Lee, J. M., Hazra, S., Lin, Y., Walser, T. C., Schaue, D., Pak, P. S., Elashoff, D. A., Reckamp, K. L., Zhang, L., et al. (2010) · PubMed Central · Cited by 67
Liu, C., Shi, Y., Du, Y. F., Ning, X., LIU, N., Huang, D., Liang, J., Xue, Y., & FAN, D. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.06.022 · Cited by 67
Intracellular Pathways Linking Hypoxia to Activation of c-fos and AP-1
Premkumar, D. R., Adhikary, G., Overholt, J. L., Simonson, M. S., Cherniack, N. S., & Prabhakar, N. R. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_10 · Cited by 66
Wu, M., Lin, S., Hsiao, K., & Tsai, S. (2011) · The Journal of Pathology · doi:10.1002/path.2963 · Cited by 65
Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells
Jiang, Y., Zhu, Y. J., Wang, X., Gong, J., Hu, C., Guo, B., Zhu, B., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3352 · Cited by 64
Varney, M. L., Olsen, K. J., Mosley, R. L., & Singh, R. K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.674 · Cited by 63
Synergy between anti‐CCL2 and docetaxel as determined by DW‐MRI in a metastatic bone cancer model
Rozel, S., Galbán, C. J., Nicolay, K., Lee, K. C., Sud, S., Neeley, C. K., Snyder, L. A., Chenevert, T. L., Rehemtulla, A., Ross, B. D., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22056 · Cited by 62
HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization
Azoitei, N., Diepold, K., Brunner, C., ROUHI, A. M., Genze, F., Becher, A., Kestler, H. A., Lint, J. V., Chiosis, G., Koren, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1017 · Cited by 60
Molecular Pathways of Spontaneous and TNF-α–Mediated Neutrophil Apoptosis under Intermittent Hypoxia
Dyugovskaya, L., Polyakov, A., Ginsberg, D., Lavie, P., & Lavie, L. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0025oc · Cited by 60
Song, D., Fang, G., Mao, S., Ye, X., Liu, G., Miller, E. J., Greenberg, H. E., & Liu, S. F. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.027 · Cited by 60
Hao, S., Zhu, X., Liu, Z., Wu, X., Li, S., Jiang, P., & Jiang, L. (2021) · Respiratory Research · doi:10.1186/s12931-021-01655-6 · Cited by 60
Bulut, A. Ş., Erden, E., Sak, S. D., Doruk, H., Kurşun, N., & Dìnçol, D. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1250-2 · Cited by 59
Raninga, P. V., Trapani, G. D., Vučković, S., & Tonissen, K. F. (2016) · Cell Cycle · doi:10.1080/15384101.2015.1136038 · Cited by 59
Tumor-line specific pO2 fluctuations in human melanoma xenografts
Brurberg, K. G., Graff, B. A., Olsen, D. R., & Rofstad, E. K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.049 · Cited by 58
ERK and Calcium in Activation of HIF‐1
Mottet, D., Michel, G., Renard, P., Ninane, N., Raes, M. J., & Michiels, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04681.x · Cited by 58
Devapatla, B. K., Sharma, A., & Woo, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139237 · Cited by 58
Quintero, M., Gonzalez-Martin, M. D. C., Vega‐Agapito, V., González, C., Obeso, A., Farré, R., Agapito, T., & Yubero, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.180 · Cited by 57
Targeting lipid mediators in cancer biology
Sulciner, M. L., Gartung, A., Gilligan, M. M., Serhan, C. N., & Panigrahy, D. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9754-9 · Cited by 57
Effects of different hypoxia degrees on endothelial cell cultures—Time course study
Bâldea, I., Teacoe, I. D., Olteanu, D. E., Vaida-Voievod, C., Clichici, A., Sîrbu, A. C., Filip, G. A., & Clichici, S. V. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.003 · Cited by 56
Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox
Lamadema, N., Burr, S., & Brewer, A. C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.009 · Cited by 54
Olbryt, M., Habryka, A., Student, S., Jarząb, M., Tyszkiewicz, T., & Lisowska, K. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105104 · Cited by 53
Liu, H., Xiao, J., Yang, Y., Liu, Y., Ma, R., Li, Y., Deng, F., & Zhang, Y. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.04.011 · Cited by 52
Intermittent hypoxia alleviates increased VEGF and pro‑angiogenic potential in liver cancer cells
Dong, G., Lin, X., Liu, H., Gao, D., Cui, J., Ren, Z., & Chen, R. (2019) · Oncology Letters · doi:10.3892/ol.2019.10486 · Cited by 52
Involvement of COX‐2/PGE2 signalling in hypoxia‐induced angiogenic response in endothelial cells
Zhao, L., Wu, Y., Xu, Z., Wang, H., Zhao, Z., Li, Y., Yang, P., & Wei, X. C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01479.x · Cited by 51
Gutsche, K., Randi, E. B., Blank, V., Fink, D. A., Wenger, R. H., Leo, C., & Scholz, C. C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.002 · Cited by 51
de Porras, V. R., Wang, X. C., Palomero, L., Marín‐Aguilera, M., Solé-Blanch, C., Indacochea, A., Jiménez, N., Bystrup, S., Bakht, M. K., Conteduca, V., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.10.001 · Cited by 51
Naidu, B. V., Krishnadasan, B., Byrne, K., Farr, A. L., Rosengart, M., Verrier, E. D., & Mulligan, M. S. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03746-3 · Cited by 50
Gu, X., Zhang, J., Shi, Y., Shen, H., Li, Y., Chen, Y., & Liang, L. (2020) · Oncology Reports · doi:10.3892/or.2020.7913 · Cited by 50
Li, J., Yuan, W., Jiang, S., Ye, W., Yang, H., Shapiro, I. M., & Risbud, M. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611483 · Cited by 49
Miyake, M., Furuya, H., Onishi, S., Hokutan, K., Anai, S., Chan, O. T. M., Shi, S., Fujimoto, K., Goodison, S., Cai, W., et al. (2019) · Theranostics · doi:10.7150/thno.29553 · Cited by 48
Alterations of histone modifications by cobalt compounds
Li, Q., Ke, Q., & Costa, M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp088 · Cited by 46
Intermittent hypoxia induces NF-κB-dependent endothelial activation via adipocyte-derived mediators
Lee, M. Y. K., Wang, Y., Mak, J., & Ip, M. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00240.2015 · Cited by 46
An, J., Ying, X., Long, M., Zhang, G., Zhang, J., & Su, H. (2017) · Oncotarget · doi:10.18632/oncotarget.16837 · Cited by 46
Cited by
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Bai, R., Li, Y., Jian, L., Yang, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 279
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Korbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-02
- Volume
- 22
- Issue
- 19
- Pages
- 10701
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3203803079
- Cited by
- 380
- References
- 258
- FWCI
- 16.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.